Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

JOE SCARBOROUGH, Host: Six out of every 1,000 kids get it, and nobody knows exactly why. But my next guest says ... part of the blame ... needs to fall on government. And it has to do with a drug called thimerosal. Robert F. Kennedy Jr. is a senior attorney for the Natural Resources Defense [Council]. Let's talk tonight about thimerosal. There are a lot of people out there ... very concerned about the impact of this drug, which is found in vaccines, and how it causes autism. Talk about that. ROBERT F. KENNEDY JR.: That's right. Thimerosal is a preservative that was put in vaccines back in the 1930s. Almost immediately after it was put in, autism cases began to appear. Autism had never been known before. It was unknown to science. Then the vaccines were increased in 1989 by the CDC and by a couple of other government agencies. What happened was the vaccine schedule was increased. We went up from receiving about 10 vaccines in our generation to these kids receive 24 vaccines. And they all had this thimerosal in them, this mercury. And nobody bothered to do an analysis of what the cumulative impact of all that mercury was doing to kids. As it turns out, we are injecting our children with 400 times the amount of mercury that FDA or EPA considers safe. A child on his first day that he is born is injected with a hepatitis B shot. Under EPA guidelines, he would have to be 275 pounds to safely absorb that shot. What happened was that, in 1988, one in every 2,500 American children had autism. Today, one in every 166 children have autism.

Note: Read an excellent article by Robert F. Kennedy, Jr. revealing severe manipulations around vaccines. Then see a video clip of the above interview. Watch a great video raising serious questions on the efficacy of vaccines and legality of mandatory vaccines. Full text is included. A great 13-minute video shows the developed country with the least vaccinated children also has the healthiest children, while the US has the most vaccinated and least healthy kids. For more, see concise summaries of deeply revealing news articles on vaccine controversies.

Scientists have the first evidence that life-threatening peanut allergies may be cured one day. A few kids now are allergy-free thanks to a scary treatment — tiny amounts of the very food that endangered them. Don’t try this at home. Doctors monitored the youngsters closely in case they needed rescue, and there’s no way to dice a peanut as small as the treatment doses required. But over several years, the children’s bodies learned to tolerate peanuts. Immune-system tests show no sign of remaining allergy in five youngsters, and others can withstand amounts that once would have left them wheezing or worse. “We’re optimistic that they have lost their peanut allergy,” said the lead researcher, Dr. Wesley Burks, Duke’s allergy chief. Rhonda Cassada['s] 7-year-old son, Ryan, has been labeled allergy-free for two years and counting. It’s a big change for a child who couldn’t tolerate one-sixth of a peanut when he entered the study at age 2 1/2. By 5, Ryan could eat a whopping 15 peanuts at a time with no sign of a reaction. More rigorous research is under way to confirm the pilot study, released Sunday at a meeting of the American Academy of Asthma and Immunology. If it pans out, the approach could mark a major advance for an allergy that afflicts 1.8 million people in the United States. Millions of people have food allergies and peanut allergy is considered the most dangerous, with life-threatening reactions possible from trace amounts. It accounts for most of the 30,000 emergency-room visits and up to 200 deaths attributed to food allergies each year. Although some children outgrow peanut allergy, that’s rare among the severely affected. There’s no way to avoid a reaction other than avoiding peanuts.

Note: For many hopeful reports on health issues from major media sources, click here.

Ten years after he was diagnosed HIV-positive, Paul was still alive. This was long before tri-therapy—the remarkably effective treatment that keeps AIDS patients alive—and everyone asked what he was doing to stave off the illness. He replied that he was taking natural supplements, watching his diet carefully and exercising regularly. One day at a press conference, a professor of medicine told him, "I'm sorry to say I've had a lot of patients who were doing the same thing and they all died. Unfortunately, I expect that within a year, or at most two, your disease will have gotten the upper hand." Indeed, Paul died within two years, his hopes struck down by that terrible omen. It takes 24 hours for certain voodoo priests to bring about the death of a person on whom they've cast an "evil spell." The grand priests of modern medicine aren't so quick but can sometimes be as deadly. Cancer seems to develop faster and more aggressively in patients who have less control over the inevitable stress of existence, which seems to be one of the reasons support groups prolong survival. Now what could be more stressful than being told there's no hope of a cure? At the University of California, Los Angeles, Assistant Professor Steve Cole demonstrated that among AIDS patients on tri-therapy, the treatment benefits those who remain calm facing life's difficulties far more than those who have trouble controlling their stress. To guard against this Western-style voodoo, patients often need to know more than their doctors about what they can do to help themselves—beginning by placing more hope in their bodies than medicine is prepared to give them.

Note: For many hopeful reports on health issues from major media sources, click here.

Retirement slammed Carole Jacko. Raising two grandchildren, she's too young for Medicare and too strapped to pay $600 a month for health insurance. So when a trip to the emergency room ended with a diagnosis of diabetes, Jacko found a creative solution. She became a medical guinea pig, offering herself to science in exchange for free medication, free doctor's visits and even a modest payment. With the economy careening and millions uninsured, some doctors and researchers believe the lure of volunteering for medical research is growing – and so are potential ethical pitfalls. "Sometimes desperation leads people to be poor shoppers," to gloss over risks or grasp at imagined benefits, said Kevin Weinfurt, a Duke University professor who focuses on medical decision-making and ethics. No regulations limit how much a person can be paid to take part in medical research. Researchers do not agree on how much money it takes to cross the line and exert "undue influence" or coercion to get someone to enroll in a study. That's something federal regulations do forbid. "This is the most complicated issue in research ethics, and it's still an unsettled question," Weinfurt said. It has lingered for more than 100 years, since an Army surgeon named Walter Reed paid volunteers at a Cuban outpost $100 in gold to risk being infected with yellow fever. The men got another $100 if they contracted the disease, payable to themselves – or any designated survivor.

Note: For many reports on corruption in the pharmaceutical and medical industries from major media sources, click here.

DNA molecules can display what almost seems like telepathy, research now reveals. Double helixes of DNA can recognize matching molecules from a distance and then gather together, all seemingly without help from any other molecules, scientists find. Previously, under the classic understanding of DNA, scientists had no reason to suspect that double helixes of the molecule could sort themselves by type, let alone seek each other out. Scientists investigated double-stranded DNA tagged with fluorescent compounds. These molecules were placed in salt water that contained no proteins or other material that could interfere with the experiment or help the DNA molecules communicate. Curiously, DNA with identical sequences of bases were roughly twice as likely to gather together as DNA molecules with different sequences. Although it looks as if spooky action or telepathic recognition is going on, DNA operates under the laws of physics, not the supernatural. The bases that make up a strand of DNA each cause the corkscrew to bend one way or the other. Double-stranded DNA with identical sequences each result in corkscrews "whose ridges and grooves match up," said researcher Sergey Leikin, a physical biochemist. Identical DNA double helixes have matching curves, meaning they repel each other the least, Leikin explained. The scientists conjecture such "telepathy" might help DNA molecules line up properly before they get shuffled around. This could help avoid errors in how DNA combines, errors that underpin cancer, aging and other health problems.

Spontaneous tumor regressions are among the rarest and most mysterious events in medicine, with only several hundred cases in the literature that can be considered well documented. Regressions have most often been reported in melanoma and in kidney cancer. But the phenomenon may, in fact, be an everyday one, taking place beyond doctors' eyes. A recent study suggests that as many as 1 in 3 breast tumors may vanish on their own before being detected by a doctor. Why do some patients get lucky? Scientists are finding tantalizing evidence that the immune system, the body's defense against disease-causing microbes, kicks in to play a critical role in combating cancer. The evidence includes the fact that some unexplained remissions have occurred after infections, which may propel the immune system into high gear--possibly attacking the cancer tumor as well as the infection. The role of the immune system in controlling cancer has been hotly debated for decades--and indeed many scientists remain unconvinced. But Jedd D. Wolchok, an oncologist at New York's Memorial Sloan-Kettering Cancer Center, thinks there is a connection. A spontaneous remission, he says, is "either divine intervention or the immune system." While few researchers directly study such cases--they are far too rare--they provide hints of what the immune system might be able to do if we could harness it.

Note: The number of these cancer miracles are likely far more than suggested in this article. The problem is that most doctors ignore or consider them insignificant. For a most fascinating example of this, click here. For many exciting reports from major media sources describing potentially promising new cancer treatments, click here.

Some ... favorite gee-whiz moments from this year's TED conference: -- UC Berkeley biologist Robert Full blew everyone's mind by outlining his efforts to create the perfect robotic "distributed foot." He studies the feet and legs of geckos and cockroaches and transfers their design to robots, enabling them to scale walls. One such machine, the Spinybot, can climb glass walls. -- P.W. Singer, an academic who studies war, terrified the crowd with a detailed look at modern, robotic warfare. Something I didn't know: You can sit in a room in New Mexico and pilot armed drone airplanes in Iraq and kill people. Then you go home and have dinner with your kids. Somewhere, Aldous Huxley weeps. -- Stanford's Catherine Mohr displayed the robotic surgical arm she's working on that could change medicine. Among the amazing possibilities are surgeons in the United States performing advanced surgeries in remote parts of the world. These are just a handful of the amazing innovations and disclosures made at TED this year. In the coming weeks and months, videos of all of these talks will be made available to the public at www.ted.com. TED, which stands for Technology, Entertainment, Design, is a 25-year-old annual conference attended by many of the world's leading scientists, academics and business leaders. The agenda consists of a series of talks, during which big thinkers discuss big ideas.

Note: For powerful information on bizarre "non-lethal" weapons developed by the military, click here. For an enlightening NPR interview on artificial war, click here. And for one of the most powerful TED presentations ever, see neuroanatomist Jill Bolte Taylor's description of her experience having a stroke, available here.

Ask mothers why babies are constantly picking things up from the floor or ground and putting them in their mouths, and chances are they’ll say that it’s instinctive — that that’s how babies explore the world. But why the mouth, when sight, hearing, touch and even scent are far better at identifying things? Accumulating evidence strongly suggests that eating dirt is good for you. In studies of what is called the hygiene hypothesis, researchers are concluding that organisms like the millions of bacteria, viruses and especially worms that enter the body along with “dirt” spur the development of a healthy immune system. Several continuing studies suggest that worms may help to redirect an immune system that has gone awry and resulted in autoimmune disorders, allergies and asthma. These studies, along with epidemiological observations, seem to explain why immune system disorders like multiple sclerosis, Type 1 diabetes, inflammatory bowel disease, asthma and allergies have risen significantly in the United States and other developed countries. “What a child is doing when he puts things in his mouth is allowing his immune response to explore his environment,” Mary Ruebush, a microbiology and immunology instructor, wrote in her new book, Why Dirt Is Good. “Not only does this allow for ‘practice’ of immune responses, which will be necessary for protection, but it also plays a critical role in teaching the immature immune response what is best ignored.”

Note: For many key reports on new health research from reliable sources, click here.

Prozac, the bestselling antidepressant taken by 40 million people worldwide, does not work and nor do similar drugs in the same class, according to a major review released today. The study examined all available data on the drugs, including results from clinical trials that the manufacturers chose not to publish at the time. The trials compared the effect on patients taking the drugs with those given a placebo or sugar pill. When all the data was pulled together, it appeared that patients had improved - but those on placebo improved just as much as those on the drugs. The only exception is in the most severely depressed patients, according to the authors - Prof Irving Kirsch from the department of psychology at Hull University and colleagues in the US and Canada. But that is probably because the placebo stopped working so well, they say, rather than the drugs having worked better. "Given these results, there seems little reason to prescribe antidepressant medication to any but the most severely depressed patients, unless alternative treatments have failed," says Kirsch. "This study raises serious issues that need to be addressed surrounding drug licensing and how drug trial data is reported." The paper, published today in the journal PLoS (Public Library of Science) Medicine, is likely to have a significant impact on the prescribing of the drugs. The National Institute for Health and Clinical Excellence already recommends that counselling should be tried before doctors prescribe antidepressants.

Note: For many key reports on health issues from reliable sources, click here.

Virtually all the dominant strain of flu in the United States this season is resistant to the leading antiviral drug Tamiflu, and scientists and health officials are trying to figure out why. The problem is not yet a public health crisis because this has been a below-average flu season so far, and because the Tamiflu-resistant strain, one of three circulating, is still susceptible to other drugs. But infectious disease specialists are worried nonetheless. Last winter, about 11 percent of the throat swabs from patients with the most common type of flu that were sent to the Centers for Disease Control and Prevention for genetic typing showed a Tamiflu-resistant strain. This season, 99 percent do. “It’s quite shocking,” said Dr. Kent A. Sepkowitz, director of infection control at Memorial Sloan-Kettering Cancer Center in New York. “We’ve never lost an antimicrobial this fast. It blew me away.” The single mutation that creates Tamiflu resistance appears to be spontaneous, and not a reaction to overuse of the drug. Complicating the problem, antiviral drugs work only if taken within the first 48 hours of infection.

Note: Isn't Tamiflu the same drug that was, according the the U.K.'s respected Independent, "bought in massive amounts by Governments to treat a possible human pandemic of the disease [avian flu]," and from which Donald Rumsfeld "made more than $5m in capital gains from selling shares"? What ever happened to all the panic about the avian flu? Could it be that it was only fear mongering? For reliable information on this key topic, click here.

What do you do when one arm of the government says everything is O.K. and another tells you to watch out? That is what is happening with bisphenol-A — a chemical used in many plastics and epoxy resins now found in baby bottles and liners for canned goods. The answer is a truism in every family rulebook — when in doubt, especially when it comes to children, err on the side of caution. That means it is a good idea to keep the young away from bisphenol-A, or BPA. Then this week, the National Toxicology Program, the federal agency for toxicological research, reported that their research shows “some concern” about the effects of BPA on the brain development and behavior of fetuses and young children. A new study by the Yale School of Medicine is cause for even more concern. In tests on primates, researchers found that BPA “causes the loss of connections between brain cells” that could cause memory or learning problems and depression.” John Bucher, the associate director of the toxicology program, said ... "We have concluded that the possibility that BPA may affect human development cannot be dismissed.”

Note: For many key reports on health issues from reliable sources, click here.

The Food and Drug Administration, criticized by its own scientific advisers for ignoring available data about health risks posed by a chemical found in everyday plastic, said yesterday it has no plans to amend its position on the substance but will continue to study it. The agency has been reviewing its risk assessments for bisphenol A, a chemical used to harden plastic that is found in a wide variety of products, from baby bottles to compact discs to the lining of canned goods. The chemical, commonly called BPA, mimics estrogen and may disrupt the body's carefully calibrated endocrine system. Over the past decade, more than 130 studies have linked BPA to breast cancer, obesity, diabetes, neurological problems and other disorders. Much of the new research suggests that BPA has an effect at very low doses -- lower than the current safety standard set by the FDA. The most prominent finding was by the National Toxicology Program, part of the National Institutes of Health, which reported that there is "some concern" that BPA may affect the brain and behavioral development of fetuses, infants and young children. In October, the FDA was faulted by its own panel of independent science advisers, who said the agency's position on BPA was scientifically flawed. Yesterday, Laura Tarantino, director of the FDA's Office of Food Additive Safety, said the FDA will respond to that recommendation by performing additional analysis. She said she did not know if it would last months or years. "I can't tell you when we will finalize this," she said.

Note: For important new results in health research from reliable sources, click here.

A careless touch could be all police or insurance companies need to determine not only your identity, but also your past drug use, if you've fired a gun or handled explosives, even specific medical conditions. "A fingerprint is only good to identify a criminal if you already have their fingerprint on file," said David Russell, a professor at the University of East Anglia, who, along with Pompi Hazarika, helped developed [a new analytical] technique. "This will give police new tools to help discover that identity." For decades forensic scientists have dusted fingerprints with magnetic particles to reveal the hidden swirls and curls that differentiate each person on the planet. The iron oxide particles attach themselves to the tiny bits of water, minerals, and oils that accumulate on the fingers as they touch various objects and other parts of the body. The new technique attaches the iron oxide particles to antibodies and suspends them both in a liquid solution, which is then drizzled over a fingerprint. If the chemical that a specific antibody targets is present, the molecules latch onto it and glow. So far the scientists can detect five different drugs: THC (marijuana), cocaine, nicotine, methadone and a derivative of methadone. Other drugs, particularly opium-based drugs like heroine or morphine, should also be detectable, since antibodies already exist for them as well. Drugs aren't the only chemicals the new tests could detect. Cancer, diabetes, heart disease and other medical conditions produce specific chemicals also secreted in sweat and oil. By tweaking the antibodies on the particles, forensic scientists could test for a variety of medical conditions.

When he was just 7 years old, Sacramento native Nate DeFelice was told he had Type 1 diabetes. So when he joined a diabetes research project at Ben-Gurion University [in Israel] two years ago, he hoped it would be a meaningful experience. As it turns out, the project could change his life and those of millions of other diabetics. DeFelice, 27, never dreamed that he would help discover a potential cure for his disease, see the beginning of a Federal Drug Administration-approved clinical trial in the United States, and co-author a scientific paper along with seven other researchers published in October by the National Academy of Sciences. Type 1 diabetes, usually diagnosed in childhood, is caused by a failure of the insulin-producing cells in the pancreas called "islets." They require daily injections of insulin, which helps break down glucose in the blood. When Ben-Gurion University biochemistry Professor Dr. Eli Lewis asked for volunteers to participate in new research on diabetes, DeFelice jumped at the chance. Lewis, DeFelice and the other researchers have focused their investigations on islet transplantation. The Israeli team then opted for a new approach, ... focusing ... on inflammation caused by the transplant itself. Lewis grafted healthy islets into diabetic mice and treated them with an anti-inflammatory drug called alpha-1-antitrypsin, or AAT. Within months, they discovered three encouraging results: AAT enabled the newly grafted islets to survive indefinitely, successfully secreting insulin. The researchers stopped administering AAT and the islets continued to function. The mice's immune systems remained intact and were able to reject additional grafts while the original transplant continued to function.

Note: For many reports on health issues from major media sources, click here.

What are the pills in your medicine cabinet, and how do you know they're best for you? When drug companies seek approval to market new medicines, they must show the U.S. Food and Drug Administration the results of all the tests they've run on volunteer patients - at first on only a few, then on dozens, and finally on hundreds or sometimes thousands. After winning approval, the companies typically sponsor reports of those tests in medical journal publications, which many doctors often rely on to determine whether to prescribe new drugs for their patients. Now a skeptical team of medical investigators at UCSF has accused the major drug companies of bias by distorting the results of their trials in those publications, making it hard for doctors to judge for themselves the pros and cons of prescribing the new drugs. As a result, the researchers say, patients may sometimes be taking medicines they don't need - or with unwanted side effects - that their doctors have prescribed on the basis of inadequate information. The UCSF team, led by Lisa A. Bero of the medical center's Institute for Health Policy Studies, probed the details of 164 drug trials involving as many as 1,500 patients over a two-year period and then examined reports on those trials that were published in medical journals, as well as those that remained unpublished. "We found really important information from the official trial reports that were either not published at all or that stressed mostly the positive results of trials in the published versions," said Kristin Rising, a physician at the institute who did the major investigation.

Note: For lots more on corporate corruption from reliable sources, click here.

In a sweeping critique ... an expert panel of the National Research Council said the federal government was not doing enough to identify potential health and environmental risks from engineered nanomaterials. Nanomaterials are engineered on the scale of a billionth of a meter, perhaps 1/10,000 the width of a human hair. They are turning up in a range of items including consumer products like toothpaste and tennis rackets and industrial products like degreasers or adhesives. But some experts say they may pose health or environmental risks. For example, researchers in Scotland reported this year that carbon nanotubes may pose the same health risks as asbestos. “Industry wants to run with it,” said Andrew D. Maynard, chief science adviser to the Project on Emerging Nanotechnologies at the Woodrow Wilson Institute, who was the chairman of the panel. But he added, “one of the big barriers at the moment is understanding how to use it safely.” The panel analyzed the risk research strategy of the National Nanotechnology Initiative, the program to coordinate federal efforts in nanotechnology research and development. Its report concluded that the initiative’s strategy “does not present a vision, contain a clear set of goals, have a plan of action for how the goals are to be achieved, or describe mechanisms to review and evaluate funded research and assess whether progress has been achieved.” An informal coalition of environmental and business organizations praised the report, saying that for three years they had been urging the federal government to do more to assess potential health and environmental effects of nanomaterials.

Note: For many important articles on health issues from reliable sources, click here.

Vitamin D-binding protein-derived macrophage activating factor (GcMAF) appears to be an effective immunotherapeutic agent in patients with metastatic breast cancer, according to US and Japanese researchers. "Serum vitamin D-binding protein -- known as Gc protein -- is the precursor of the principal macrophage activating factor," lead investigator Dr. Nobuto Yamamoto told Reuters Health. "Treatment of purified Gc protein with beta-galactosidase and sialidase generates GcMAF," he added, "the most potent macrophage activating factor ever discovered, which produces no side effect in humans." Dr. Yamamoto of the Socrates Institute for Therapeutic Immunology, Philadelphia and colleagues note that in vitro studies show that macrophages treated with GcMAF have a highly tumoricidal effect in mammary adenocarcinomas. To investigate whether the approach can be effective in humans, the researchers studied 16 non-anemic breast cancer patients who were given "a minute amount -- 100 nanograms per week -- of GcMAF," Dr. Yamamoto said. The researchers found that after 16 to 22 GcMAF doses, initially elevated nagalase levels, which reflect the tumor burden, fell to those found in healthy controls. Follow-up over 4 years showed that the level remained low and that there was no tumor recurrence, they report in the January 15th issue of The International Journal of Cancer. The findings, the team concludes, clearly demonstrate "the importance of focusing cancer immunotherapy on macrophage activation."

Note: Another article from the National Institutes of Health website covers an experiment with colorectal cancer patients using this amazing discovery. It states that "all colorectal cancer patients exhibited healthy control levels of the serum Nagalase activity, indicating eradication of metastatic tumor cells." Why isn't this getting more major press coverage?

The male [sex] is in danger, with incalculable consequences for both humans and wildlife, startling scientific research from around the world reveals. The research ... shows that a host of common chemicals is feminising males of every class of vertebrate animals, from fish to mammals, including people. Backed by some of the world's leading scientists, who say that it "waves a red flag" for humanity and shows that evolution itself is being disrupted, the report comes out at a particularly sensitive time for ministers. It also follows hard on the heels of new American research which shows that baby boys born to women exposed to widespread chemicals in pregnancy are born with smaller penises and feminised genitals. "This research shows that the basic male tool kit is under threat," says Gwynne Lyons, a former government adviser on the health effects of chemicals, who wrote the report. Wildlife and people have been exposed to more than 100,000 new chemicals in recent years, and the European Commission has admitted that 99 per cent of them are not adequately regulated. There is not even proper safety information on 85 per cent of them. Many have been identified as "endocrine disrupters" – or gender-benders – because they interfere with hormones. These include phthalates, used in food wrapping, cosmetics and baby powders among other applications; flame retardants in furniture and electrical goods; PCBs, a now banned group of substances still widespread in food and the environment; and many pesticides.

Note: For many key reports on health issues from reliable sources, click here.

Neuroscientists have shown that they can [create] a “body swapping” illusion that could have a profound effect on a range of therapeutic techniques. At the annual meeting of the Society for Neuroscience last month, Swedish researchers presented evidence that the brain, when tricked by optical and sensory illusions, can quickly adopt any other human form, no matter how different, as its own. “You can see the possibilities, putting a male in a female body, young in old, white in black and vice versa,” said Dr. Henrik Ehrsson of the Karolinska Institute in Stockholm. The technique is simple. A subject stands or sits opposite the scientist, as if engaged in an interview. Both are wearing headsets, with special goggles, the scientist’s containing small film cameras. The goggles are rigged so the subject sees what the scientist sees: to the right and left are the scientist’s arms, and below is the scientist’s body. To add a physical element, the researchers have each person squeeze the other’s hand, as if in a handshake. Now the subject can see and “feel” the new body. In a matter of seconds, the illusion is complete. In a series of studies, using mannequins and stroking both bodies’ bellies simultaneously, the Karolinska researchers have found that men and women say they not only feel they have taken on the new body, but also unconsciously cringe when it is poked or threatened. In previous work, neuroscientists have induced various kinds of out-of-body experiences using similar techniques. The brain is so easily tricked, they say, precisely because it has spent a lifetime in its own body.

Public health groups, consumer advocates and members of Congress blasted the Food and Drug Administration yesterday for failing to act after discovering trace amounts of the industrial chemical melamine in baby formula sold in the United States. "This FDA, this Bush administration, instead of protecting the public health, is protecting industry," said Rep. Rosa DeLauro (D-Conn.), who chairs the Appropriations subcommittee that oversees the FDA budget. "We're talking about babies, about the most vulnerable. This really makes me angry." The FDA found melamine and cyanuric acid, a related chemical, in samples of baby formula made by major U.S. manufacturers. Melamine can cause kidney and bladder stones and, in worst cases, kidney failure and death. If melamine and cyanuric acid combine, they can form round yellow crystals that can also damage kidneys and destroy renal function. Melamine was found in Good Start Supreme Infant Formula With Iron made by Nestle, and cyanuric acid was detected in Enfamil Lipil With Iron infant formula powder made by Mead Johnson. The FDA has been testing hundreds of food products for melamine in the aftermath of a scandal this year involving Chinese infant formula tainted with melamine. Chinese manufacturers deliberately added the chemical to watered-down formula to make it appear to contain higher levels of protein. More than 50,000 Asian infants were hospitalized, and at least four died.

Note: For many reports on government corruption from major media sources, click here.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.